# Odaia Intelligence

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/odaia-intelligence

- Industry: Software
- Headquarters: Toronto, Canada
- Website: www.odaia.ai
- Total disclosed funding: $40M
- Latest round: Series B (May 1, 2023)
- Investors on record: 12

## About

Odaia Intelligence Inc. offers AI-driven intelligence solutions to enhance pharmaceutical commercial operations, focusing on actionable insights for healthcare professionals through innovative technologies.Founded in 2018 and headquartered in Toronto, Canada, Odaia Intelligence Inc. specializes in AI solutions for the pharmaceutical sector. The company has successfully raised CAD 34.00 mn in its Series B funding round on May 1, 2023, with participation from investors including Monograph Capital Partners and Threshold Ventures. The founders, Helen Kontozopoulos, Periklis Andritsos, and Philip Poulidis, have a history of contributing to the technology and healthcare industries.Odaia specializes in AI-powered intelligence solutions tailored for pharmaceutical commercial teams. The company's core product, the MAPTUAL platform, leverages explainable machine learning to process data and deliver actionable insights regarding healthcare professionals (HCPs) and their patient decision-making processes. ODAIA Field is another key offering, providing sales representatives with prioritized call lists and timely insights that facilitate meaningful engagements with both new and existing customers. These products are designed to address the limitations of traditional segmentation methods, enhancing the efficiency of targeting and engagement in the dynamic pharmaceutical landscape. Odaia's clientele comprises innovative biopharmaceutical companies, ranging from large-scale entities to emerging players, with products utilized across North American and European markets.Odaia operates primarily on a subscription-based revenue model, where clients pay for access to its suite of products and services, including MAPTUAL and ODAIA Field. The company supports over 20 brands annually, generating revenue that significantly contributes to the pharmaceutical sector, with documented figures indicating an average weekly utilization rate of 85%. Revenue generation is closely tied to partnerships with pharmaceutical companies that leverage Odaia's analytics for insights into their marketing and sales strategies. By providing targeted intelligence that enhances HCP engagement, Odaia underpins commercial success for its clients, which directly impacts their prescription volume and market performance. The transactional structure is designed to foster long-term relationships with clients, ensuring continuous support and updates to the platform as market dynamics evolve.In April 2023, Odaia Intelligence Inc. raised CAD 34.00 mn in Series B funding, co-led by new investors Monograph Capital Partners, Threshold Ventures, and Wittington Ventures, with continued support from returning investors. The company plans to utilize this funding to further advance its artificial intelligence capabilities. Looking ahead, Odaia is focused on expanding its product offerings and enhancing existing technologies to meet the evolving needs of its customers. Additionally, the company aims to extend its market reach into new geographic regions, with specific plans to penetrate emerging markets in Asia by the end of 2024.

## Funding rounds

- Series B, May 1, 2023, $25M — BDC Capital, Flint Capital, StandUp Ventures, Wittington Ventures, Threshold Ventures, Monograph Capital, Graphite Ventures
- Series A, Feb 10, 2022, $14M — BDC Capital, Flint Capital, MaRS Investment Accelerator Fund, Alumni Ventures Group, StandUp Ventures, Panache Ventures, Innospark Ventures, Graphite Ventures
- Seed, Sep 23, 2019, $1.6M — BDC Capital, Inovia Capital, MaRS Investment Accelerator Fund, StandUp Ventures, Panache Ventures

## Investors

- BDC Capital (https://capitalatlas.ai/funds/bdc-capital) — Seed, Series A, Series B
- Inovia Capital (https://capitalatlas.ai/funds/inovia-capital) — Seed
- MaRS Investment Accelerator Fund (https://capitalatlas.ai/funds/mars-investment-accelerator-fund) — Seed, Series A
- StandUp Ventures (https://capitalatlas.ai/funds/standup-ventures) — Seed, Series A, Series B
- Panache Ventures (https://capitalatlas.ai/funds/panache-ventures) — Seed, Series A
- Flint Capital (https://capitalatlas.ai/funds/flint-capital) — Series A, Series B
- Alumni Ventures Group (https://capitalatlas.ai/funds/alumni-ventures-group) — Series A
- Innospark Ventures (https://capitalatlas.ai/funds/innospark-ventures) — Series A
- Graphite Ventures (https://capitalatlas.ai/funds/graphite-ventures) — Series A, Series B
- Wittington Ventures (https://capitalatlas.ai/funds/wittington-ventures) — Series B
- Threshold Ventures (https://capitalatlas.ai/funds/threshold-ventures) — Series B
- Monograph Capital (https://capitalatlas.ai/funds/monograph-capital) — Series B